States Cautiously Re-Roll Out J&J Vaccines Amid More Possible Clot Cases
Reports from Florida say people were about 50/50 in favor of the Johnson & Johnson shot versus Pfizer's version on the second day of the vaccine's availability in the wake of the temporary halt due to suspected cases of rare blood clots.